Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.13% | -25.05% | -12.76% | 4.23% | 12.47% |
| Total Depreciation and Amortization | 37.16% | 19.42% | -19.55% | -13.97% | -8.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.34% | 88.32% | 139.38% | 85.78% | 70.22% |
| Change in Net Operating Assets | -15.62% | 80.38% | 113.45% | 94.15% | 57.11% |
| Cash from Operations | -3.09% | 14.03% | 43.54% | 42.05% | 39.06% |
| Capital Expenditure | -150.92% | -60.11% | 41.16% | 8.47% | 10.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 359.77% | 314.77% | 173.38% | 103.13% | 27.01% |
| Cash from Investing | 223.71% | 582.35% | 3,533.33% | 3,356.25% | 41.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 27.78% | -42.10% | -241.93% | -280.67% | -305.09% |
| Issuance of Common Stock | 154.38% | 0.61% | -67.53% | -27.12% | -26.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.21% | 33.40% | 43.54% | 20.92% | 12.78% |
| Cash from Financing | 266.03% | 1.58% | -93.28% | -52.97% | -44.06% |
| Foreign Exchange rate Adjustments | 2,080.00% | -169.90% | -264.74% | -186.87% | 75.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,279.60% | 37.63% | -344.85% | 19.89% | -5.15% |